News

A tiny genetic mutation in the SARS-CoV-2 variant circulating throughout Europe and the United States significantly increases the virus’ ability to infect cells.

Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes.

UNC School of Medicine scientists and colleagues developed a new kind of antibody test - a simplified experimental assay that could be ramped up to test thousands of blood samples at labs that do not have the resources of commercial labs and large academic medical centers.

Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma, the most common form of liver cancer. The approach uses a simple blood test to check for the patient’s previous exposure to certain viruses.

A research has proposed a new computational system to expand the understanding of the brain at an intermediate level, between neurons and cognitive phenomena such as language. The group has developed a brain architecture that is based on neuronal assemblies, and they demonstrate its use in the syntactic processing in the production of language.

A new review of neurological symptoms of COVID-19 patients in current scientific literature reveals the disease poses a global threat to the entire nervous system, reports a new study.

Fentanyl tops the list of drugs detected in overdose patients at two Baltimore hospital emergency departments. The finding suggests that hospitals and medical systems should consider adding fentanyl, a potent synthetic opioid linked to most fatal overdoses in Maryland, to their routine drug testing panels.

A high-resolution structure of an activated dopamine receptor in its natural cell membrane environment, developed by researchers, could open up a new dimension in drug discovery for Parkinson’s disease.

Researchers from Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI) have shown for the first time, the mental health significance of hallucinations in people with a history of seizures.

The US Food and Drug Administration has approved nivolumab for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.